Conjunctivitis Treatment Market

Conjunctivitis Treatment Market Size

Conjunctivitis is an infectious eye infection in which bacteria like Staphylococci, Gonococci, Chlamydia, and Streptococci invade the conjunctiva of either or both eyes. The infection caused by the species Chlamydia trachomatis and Neisseria gonorrhoea is extremely severe. However, several medicines tend to treat these problems, making sure that the signs of infection are clearer quickly. Currently, there are many antibiotics used for the procedure, including Besivance, Zymaxid, Maxitrol, and AzaSite. These antibiotics can be given through oral, transdermal, and otic agents. While most bacterial conjunctivitis is self-limiting, it is suggested that topical antibiotics cut the length of the disease and prevent infection from spreading. Generally, a wide variety of antibiotics is used as a primary treatment choice for bacterial conjunctivitis. It is proposed that topical antibiotics deliver the maximum dose of the drug straight to the site of the infection, rather than what is normally done by oral and other paths. As a result, the wide range of single-drug antibiotics is enhanced.

Market Highlights

Global Conjunctivitis Treatment Market size was registered at USD 3.9 billion in 2020 and is estimated to reach USD XX billion by 2030, registering a CAGR of 3.80% from 2020 to 2030. The global demand for treating conjunctivitis is also driven by increasing air pollution in major cities across the globe. This is due to the vulnerability of the conjunctive to environmental particles, along with the direct interaction of the conjunctiva with the external environment. The increase in air pollution thus propels the global demand for treating conjunctivitis. New treatment options for conjunctivitis are being created by pharmaceutical firms where its efficacy in the treatment of ocular itching is being tested. All this research is funded by large pharmaceutical firms. These factors are boosting the growth of the global market for treating conjunctivitis.

 Global Conjunctivitis Treatment Market Opportunity Analysis

Source: Fatpos Global

Global Conjunctivitis Treatment Market: Segments

Conjunctivitis Treatment Market is segmented based on disease type, formulation type, and region.

By Disease Type (in %), Conjunctivitis Treatment Market, 2020

The allergic conjunctivitis segment is anticipated to register XX% of the market share during the forecasted period.

By disease type, the market can be segmented into allergic conjunctivitis, bacterial conjunctivitis, and viral conjunctivitis. Allergic conjunctivitis is normal and causes sudden swelling and ocular itching in the eyelids. Allergic conjunctivitis is more likely to occur in persons who have allergies. Disease diagnosis is generally performed by yourself. However, if anyone is unable to diagnose the condition, such tests are conducted by the doctor to recognize the condition and its cause. Treatment for acute conjunctivitis requires oral or over-the-counter (OTC) medications that minimize histamine release. Also, there are readily available on the market anti-inflammatory or anti-inflammatory eye drops which are found to offer relief in acute conjunctivitis. This segment is, therefore, expected to show steady growth.

By Formulation Type (in %), Conjunctivitis Treatment Market, 2019

The formulation type segment can be classified into an ointment, drags, and drops.

Source: Fatpos Global

Global Conjunctivitis Treatment Market Dynamics:

Increasing incidence of conjunctivitis cases and pollution to increase the market growth

Global demand for treating conjunctivitis is powered by an increased incidence of allergic conjunctivitis. New treatment options for conjunctivitis are being created by pharmaceutical firms where its efficacy in the treatment of ocular itching is being tested. All this research is funded by large pharmaceutical firms. These factors are boosting the growth of the global market for treating conjunctivitis. The global demand for treating conjunctivitis is also driven by increasing air pollution in major cities across the globe. This is due to the vulnerability of the conjunctive to environmental particles, along with the direct interaction of the conjunctiva with the external environment. The increase in air pollution thus propels the global demand for treating conjunctivitis.

Lack of knowledge and health insurance to hinder the market growth

Factors such as a lack of sufficient conjunctivitis diagnosis and insufficient knowledge of advanced technology are hampering the development of the global market.

Conjunctivitis Treatment Market: Regions

In terms of value and volume, North America accounted for XX% of total market volume share in 2020

Owing to the high incidence of allergic conjunctivitis, North America is the main market for conjunctivitis therapies. The market for treating conjunctivitis in the Asia Pacific is also expected to expand rapidly due to a broad population base leading to increased demand for better healthcare facilities. Rapid urbanization coupled with increased particulate emissions has increased the incidence of conjunctivitis in many Asian countries including India. However, a few factors, such as a lack of public knowledge of eye disorders and a lack of health insurance, are limiting the region’s demand.

The region segment can be further divided into five major types including North America, Latin America, Europe, APAC, and MENA.

Source: Fatpos Global

Global Conjunctivitis Treatment Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
• MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Conjunctivitis Treatment Market: Impact of COVID-19

Global pandemic COVID-19 has become global stress, not just for human lives, but also for industries across different industry verticals. The COVID-19 disease has infected several million people globally, with an increasing number of active cases daily, the duration of the pandemic is still difficult to predict. The COVID-19 pandemic outbreak around the globe is expected to adversely affect the development of the global economy. While patients with conjunctivitis appear to be at a high risk of being injected with viral conjunctiva, which is normally caused by adenovirus, it is predicted that the market will decline. Although coronavirus also causes some common signs and symptoms of the ocular, such as infection with conjunctivitis, watery discharge, photophobia, and eye irritation. Because of the strict lockdowns implemented by governments across the globe, the postponement or cancellation of non-life-threatening medical visits is anticipated to limit consumer growth as lesser conjunctivitis prescriptions would be released throughout this time span.

Conjunctivitis Treatment Market: Competitive landscape

New technological advancements in the Conjunctivitis Treatment Market, as well as large production output of the product by key players, are likely to increase the market growth. The demand for treating conjunctivitis involves both foreign and local businesses. The condition may be self-diagnosed and does not necessarily require hospitalization. Hence, for care people depend on home remedies or counter-drugs. Local businesses in different countries are doing a good job in this sector as the cost of the drug is lower and people's demand for OTC is growing.

Global Conjunctivitis Treatment Market: Key players

• Novartis AG
  • Company Overview
• Business Strategy
• Key Product Offerings
• Financial Performance
• Key Performance Indicators
• Risk Analysis
• Recent Development
• Regional Presence
  • SWOT Analysis
  • Bausch & Lomb Incorporated
  • Allergan Plc
  • NicOx S.A.
  • Alembic Pharmaceuticals
  • Sanofi S.A.
  • Pfizer Inc. 
  • Other prominent players

Global Conjunctivitis Treatment Market report also contains analysis on:

• Conjunctivitis Treatment Market segments:-
• By Disease Type:
• Allergic conjunctivitis
• Bacterial conjunctivitis
• Viral conjunctivitis
• By Formulation Type:
  • Ointment
  • Drops
  • Drugs
• Conjunctivitis Treatment Market dynamics
• Conjunctivitis Treatment Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Frequently Asked Questions (FAQ):